Skip to main content

Advertisement

Table 2 Detailed characteristics of the subjects under study

From: Gender differences in factors influencing insulin resistance in elderly hyperlipemic non-diabetic subjects

  MEN WOMEN
Controls N = 10 Mean ± SD Hyperlipemic patients N = 20 Mean ± SD p Controls N = 20 Mean ± SD Hyperlipemic patients N = 20 Mean ± SD p
BMI 25.91 ± 3.58 28.51 ± 2.60 0.030 25.36 ± 3.72 26.73 ± 3.59 0.24
HOMA IR 1.685 ± 0.771 3.137 ± 1.419 0.002 KS 1.717 ± 0.893 2.694 ± 1.011 0.001 KS
QUICKI 0,3596 ± 0,0263 0,3266 ± 0,0185 0,002 0,3603 ± 0,0281 0,3332 ± 0,0192 0,0007
Uric acid (mmol/l) 270.5 ± 65.4 379.9 ± 84.2 0.003 236.1 ± 67.0 270.8 ± 58.9*** 0.13
Glycemia (mmol/l) 5.31 ± 0.53 6.11 ± 0.95 0.029 KS 5.26 ± 0.42 5.85 ± 0.70 0.0027
Insulin (mIU/l) 6.96 ± 2.80 11.43 ± 4.50 0.016 KS 7.33 ± 3.80 10.27 ± 3.52 0.034 KS
Proinsulin intact (pmol/l) 2.68 ± 1.15 5.51 ± 2.75 0.012 KS 2.51 ± 1.76 4.49 ± 3.11 0.034 KS
C-peptide (nmol/l) 0.66 ± 0.31 1.11 ± 0.39 0.0148 0.75 ± 0.35 0.92 ± 0.34 0.22KS
Leptin (ng/ml) 3.07 ± 3.38 6.21 ± 3.78 0.012 KS 16.06 ± 13*** 17.79 ± 5.9** 0.17KS
TNFα (pg/ml) 14.2 ± 4.15 11.52 ± 2.77 0.063KS 11.65 ± 6.80 12.73 ± 9.15 0.43KS
hFABP (pg/ml) 3.86 ± 2.47 4.53 ± 1.97 0.46 3.09 ± 1.80 3.79 ± 2.00 0.41KS
ACL-IgG (IU/ml) 13.08 ± 6.75 19.63 ± 16.9 0.57KS 12.28 ± 6.38 16.35 ± 16.8 0.99KS
  1. BMI = body mass index, HOMA IR and QUICKI = homeostatic indexes of insulin resistance (see Methods), TNFα = tumor necrosis factor α, hFABP = heart fraction of fatty acid binding protein, ACL-IgG = IgG anticardiolipin. Other designations are the same as in Table 1.